Can we count your visit with Google Analytics? No ads, no profiles. Details
SSGQF
OTCIndustrials · Trading Companies & Distributors
Each weekday: the watchlist of pullbacks inside uptrends, every new ticker teardown, and the bubble shifts that move names like this one. Free. Education, not advice.
Free when you join: the $HOOD Teardown Dossier (Robinhood Markets), the full desk file we sell in the shop. One per new reader.
No spam. One email per day max, unsubscribe in one click. Pro ($49/mo) includes every dossier and report in the shop.
Trading at a steep holding-company discount to NAV - the Samsung Biologics stake alone (worth ~$15B at market) exceeds the entire market cap; any Korean conglomerate discount compression or Samsung Biologics re-rating flows directly through.
Construction backlog is weighted toward semiconductor fabs and data centers - capex cycles that remain structural. The OTC ADR provides foreign access to the Samsung equity ecosystem at a discount unavailable through direct Samsung Electronics ownership.
Conglomerate discount is structural and unlikely to fully close without activist pressure or spin-off; Korean chaebol governance remains opaque to foreign shareholders. Construction margins are thin and exposed to raw material cost spikes. OTC liquidity is low and bid/ask spreads are wide, making entries and exits costly.
No dividend policy that compensates for the discount.
It reads our $SSGQF data (thesis, key levels, peers, a year of prices) and any chart screenshot you paste, then explains the setup in plain English. Free with an email login, 5 questions a day. Education only: it never tells you to buy or sell, and it can be wrong, so check the numbers.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.